Megumi Aoki

578 citations
27 papers · 349 indexed · h-index 9
Topics
Nonmelanoma Skin Cancer Studies (8 papers)Cancer and Skin Lesions (7 papers)Cutaneous lymphoproliferative disorders research (4 papers)
Partner nations
JapanGermanySingapore

In The Last Decade

Megumi Aoki

17 papers receiving 348 citations

Peers

Megumi Aoki
Comparison fields: 5 of 49
  • Oncology 253
  • Immunology 122
  • Pulmonary and Respiratory Medicine 73
  • Molecular Biology 67
  • Epidemiology 40
Replace Chrystelle Guiter with:
Chrystelle Guiter France
Nathalie Jänner Germany
Eva M. García‐Cuesta Spain
Beatriz Chamorro Spain
Ulrike Wehkamp Germany
Charlotte M. Flynn Germany
Shaoping She China
Jong Myun Park United States
Robin Reschke Germany
Yoke Seng Lee Australia
Megumi Aoki relative to Chrystelle Guiter France Chrystelle Guiter's profile →
Citations per field
00.5×3.8×
Chrystelle Guiter · 1×
Citations per year

Countries citing papers authored by Megumi Aoki

Since Specialization
Citations

This map shows the geographic impact of Megumi Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megumi Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megumi Aoki more than expected).

Fields of papers citing papers by Megumi Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megumi Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megumi Aoki. The network helps show where Megumi Aoki may publish in the future.

Co-authorship network of co-authors of Megumi Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Megumi Aoki. A scholar is included among the top collaborators of Megumi Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megumi Aoki. Megumi Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 0
6 1
7 2
8 0
9 0
10 5
11 8
12 20
13 6
14 27
15 14
16 68
17 78
18 0
19 66
20 1

About Megumi Aoki

Megumi Aoki is a scholar working on Dermatology, Critical Care and Intensive Care Medicine and Oncology, having authored 27 papers that have together received 349 indexed citations. Recurring topics across this work include Nonmelanoma Skin Cancer Studies (8 papers), Cancer and Skin Lesions (7 papers) and Cutaneous lymphoproliferative disorders research (4 papers). The work is most often cited by research in Oncology (253 citations), Immunology (122 citations) and Microbiology (28 citations). Megumi Aoki has collaborated with scholars based in Japan, Germany and Singapore. Frequent co-authors include Shigeto Matsushita, Atsushi Otsuka, Taku Fujimura, Yumi Nonomura, Yasuhiro Fujisawa, Yuki Yamamoto, Ryota Tanaka, Takeru Funakoshi, Hiroo Hata and Katsumi Matsuzaki. Their work appears in journals such as Journal of Clinical Oncology, Biochemistry and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026